Skip to main content
Erschienen in: Journal of Cardiovascular Translational Research 6/2010

01.12.2010

Shared Desmosome Gene Findings in Early and Late Onset Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

verfasst von: Boon Yew Tan, Rahul Jain, A. Dénise den Haan, Yan Chen, Darshan Dalal, Harikrishna Tandri, Nuria Amat-Alarcon, Amy Daly, Crystal Tichnell, Cynthia James, Hugh Calkins, Daniel P. Judge

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited form of cardiomyopathy with low penetrance and variable expressivity. Dominant mutations and rare polymorphisms in desmosome genes are frequently identified. We reasoned that individuals with earlier onset disease would have more frequent desmosome gene mutations and rare polymorphisms. Three groups were compared: Young with symptoms attributable to ARVD/C or a diagnosis of ARVD/C at age of 21 years or earlier, Middle with first symptoms or diagnosis age of 22–49 years, and Late with first symptoms or diagnosis at age of 50 or more years. deoxyribonucleic acid (DNA) sequence analysis was performed on five cardiac desmosome genes, and the presence of mutations and rare missense polymorphisms was compared among the three groups. In the entire Young cohort, 20 (67%) had one or more cardiac desmosome gene mutations. The prevalence of cardiac desmosome gene mutations was similar in the Middle (48%) and Late (53%) cohorts (P = 0.23). Similar numbers of individuals in each cohort had more than one desmosome gene mutation, although the numbers are too small for statistical comparisons. The prevalence of certain rare missense DNA variants was not different among the cohorts (P = 0.71), yet these rare missense alleles were more prevalent in the overall study cohort of 112 ARVD/C participants compared to 100 race-matched controls (P = 0.027). The presence of these variants did not associate with the age of onset of ARVD/C or ventricular tachycardia. These findings highlight the complex interplay of environmental and genetic factors contributing to this condition.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Awad, M. M., Calkins, H., & Judge, D. P. (2008). Mechanisms of disease: Molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nature Clinical Practice. Cardiovascular Medicine, 5, 258–267.CrossRefPubMed Awad, M. M., Calkins, H., & Judge, D. P. (2008). Mechanisms of disease: Molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nature Clinical Practice. Cardiovascular Medicine, 5, 258–267.CrossRefPubMed
2.
Zurück zum Zitat Corrado, D., & Thiene, G. (2006). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Clinical impact of molecular genetic studies. Circulation, 113, 1634–1637.CrossRefPubMed Corrado, D., & Thiene, G. (2006). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Clinical impact of molecular genetic studies. Circulation, 113, 1634–1637.CrossRefPubMed
3.
Zurück zum Zitat Dalal, D., Molin, L. H., Piccini, J., Tichnell, C., James, C., Bomma, C., et al. (2006). Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation, 113, 1641–1649.CrossRefPubMed Dalal, D., Molin, L. H., Piccini, J., Tichnell, C., James, C., Bomma, C., et al. (2006). Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation, 113, 1641–1649.CrossRefPubMed
4.
Zurück zum Zitat Gerull, B., Heuser, A., Wichter, T., Paul, M., Basson, C. T., McDermott, D. A., et al. (2004). Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nature Genetics, 36, 1162–1164.CrossRefPubMed Gerull, B., Heuser, A., Wichter, T., Paul, M., Basson, C. T., McDermott, D. A., et al. (2004). Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nature Genetics, 36, 1162–1164.CrossRefPubMed
5.
Zurück zum Zitat Awad, M. M., Dalal, D., Cho, E., Amat-Alarcon, N., James, C., Tichnell, C., et al. (2006). DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. American Journal of Human Genetics, 79, 136–142.CrossRefPubMed Awad, M. M., Dalal, D., Cho, E., Amat-Alarcon, N., James, C., Tichnell, C., et al. (2006). DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. American Journal of Human Genetics, 79, 136–142.CrossRefPubMed
6.
Zurück zum Zitat Syrris, P., Ward, D., Evans, A., Asimaki, A., Gandjbakhch, E., Sen-Chowdhry, S., et al. (2006). Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. American Journal of Human Genetics, 79, 978–984.CrossRefPubMed Syrris, P., Ward, D., Evans, A., Asimaki, A., Gandjbakhch, E., Sen-Chowdhry, S., et al. (2006). Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. American Journal of Human Genetics, 79, 978–984.CrossRefPubMed
7.
Zurück zum Zitat Asimaki, A., Syrris, P., Wichter, T., Matthias, P., Saffitz, J. E., & McKenna, W. J. (2007). A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. American Journal of Human Genetics, 81, 964–973.CrossRefPubMed Asimaki, A., Syrris, P., Wichter, T., Matthias, P., Saffitz, J. E., & McKenna, W. J. (2007). A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. American Journal of Human Genetics, 81, 964–973.CrossRefPubMed
8.
Zurück zum Zitat McKoy, G., Protonotarios, N., Crosby, A., Tsatsopoulou, A., Anastasakis, A., Coonar, A., et al. (2000). Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet, 355, 2119–2124.CrossRefPubMed McKoy, G., Protonotarios, N., Crosby, A., Tsatsopoulou, A., Anastasakis, A., Coonar, A., et al. (2000). Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet, 355, 2119–2124.CrossRefPubMed
9.
Zurück zum Zitat Sen-Chowdhry, S., Syrris, P., & McKenna, W. J. (2005). Genetics of right ventricular cardiomyopathy. Journal of Cardiovascular Electrophysiology, 16, 927–935.CrossRefPubMed Sen-Chowdhry, S., Syrris, P., & McKenna, W. J. (2005). Genetics of right ventricular cardiomyopathy. Journal of Cardiovascular Electrophysiology, 16, 927–935.CrossRefPubMed
10.
Zurück zum Zitat Awad, M. M., Dalal, D., Tichnell, C., James, C., Tucker, A., Abraham, T., et al. (2006). Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2. Human Mutation, 27, 1157.CrossRefPubMed Awad, M. M., Dalal, D., Tichnell, C., James, C., Tucker, A., Abraham, T., et al. (2006). Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2. Human Mutation, 27, 1157.CrossRefPubMed
11.
Zurück zum Zitat den Haan, A. D., Tan, B. Y., Zikusoka, M. N., Llado, L. I., Jain, R., Daly, A., et al. (2009). Comprehensive desmosome mutation analysis in North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation: Cardiovascular Genetics, 2, 428–435.CrossRef den Haan, A. D., Tan, B. Y., Zikusoka, M. N., Llado, L. I., Jain, R., Daly, A., et al. (2009). Comprehensive desmosome mutation analysis in North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation: Cardiovascular Genetics, 2, 428–435.CrossRef
12.
Zurück zum Zitat Dalal, D., Nasir, K., Bomma, C., Prakasa, K., Tandri, H., Piccini, J., et al. (2005). Arrhythmogenic right ventricular dysplasia: A United States experience. Circulation, 112, 3823–3832.CrossRefPubMed Dalal, D., Nasir, K., Bomma, C., Prakasa, K., Tandri, H., Piccini, J., et al. (2005). Arrhythmogenic right ventricular dysplasia: A United States experience. Circulation, 112, 3823–3832.CrossRefPubMed
13.
Zurück zum Zitat Taylor, G. P. (2009). The pathology of arrhythmogenic right ventricular cardiomyopathy. In A. R. Redington, G. S. VanArsdell, & R. H. Anderson (Eds.), Congenital diseases in the right heart (pp. 125–129). London: Springer.CrossRef Taylor, G. P. (2009). The pathology of arrhythmogenic right ventricular cardiomyopathy. In A. R. Redington, G. S. VanArsdell, & R. H. Anderson (Eds.), Congenital diseases in the right heart (pp. 125–129). London: Springer.CrossRef
14.
Zurück zum Zitat Dalal, D., James, C., Devanagondi, R., Tichnell, C., Tucker, A., Prakasa, K., et al. (2006). Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 48, 1416–1424.CrossRefPubMed Dalal, D., James, C., Devanagondi, R., Tichnell, C., Tucker, A., Prakasa, K., et al. (2006). Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 48, 1416–1424.CrossRefPubMed
15.
Zurück zum Zitat Sen-Chowdhry, S., Syrris, P., & McKenna, W. J. (2007). Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 50, 1813–1821.CrossRefPubMed Sen-Chowdhry, S., Syrris, P., & McKenna, W. J. (2007). Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 50, 1813–1821.CrossRefPubMed
16.
Zurück zum Zitat Frigo, G., Bauce, B., Basso, C., & Nava, A. (2006). Late-onset arrhythmogenic right ventricular cardiomyopathy. Journal of Cardiovascular Medicine (Hagerstown), 7, 74–76.CrossRef Frigo, G., Bauce, B., Basso, C., & Nava, A. (2006). Late-onset arrhythmogenic right ventricular cardiomyopathy. Journal of Cardiovascular Medicine (Hagerstown), 7, 74–76.CrossRef
17.
Zurück zum Zitat McKenna, W. J., Thiene, G., Nava, A., Fontaliran, F., Blomstrom-Lundqvist, C., Fontaine, G., et al. (1994). Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. British Heart Journal, 71, 215–218.CrossRefPubMed McKenna, W. J., Thiene, G., Nava, A., Fontaliran, F., Blomstrom-Lundqvist, C., Fontaine, G., et al. (1994). Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. British Heart Journal, 71, 215–218.CrossRefPubMed
18.
Zurück zum Zitat Christensen, A. H., Benn, M., Tybjaerg-Hansen, A., Haunso, S., & Svendsen, J. H. (2010). Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients–disease-causing or innocent bystanders? Cardiology, 115, 148–154.CrossRefPubMed Christensen, A. H., Benn, M., Tybjaerg-Hansen, A., Haunso, S., & Svendsen, J. H. (2010). Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients–disease-causing or innocent bystanders? Cardiology, 115, 148–154.CrossRefPubMed
19.
Zurück zum Zitat Posch, M. G., Posch, M. J., Geier, C., Erdmann, B., Mueller, W., Richter, A., et al. (2008). A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Molecular Genetics and Metabolism, 95, 74–80.CrossRefPubMed Posch, M. G., Posch, M. J., Geier, C., Erdmann, B., Mueller, W., Richter, A., et al. (2008). A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Molecular Genetics and Metabolism, 95, 74–80.CrossRefPubMed
20.
Zurück zum Zitat Nishi, H., Kimura, A., Harada, H., Adachi, K., Koga, Y., Sasazuki, T., et al. (1994). Possible gene dose effect of a mutant cardiac beta-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochemical and Biophysical Research Communications, 200, 549–556.CrossRefPubMed Nishi, H., Kimura, A., Harada, H., Adachi, K., Koga, Y., Sasazuki, T., et al. (1994). Possible gene dose effect of a mutant cardiac beta-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochemical and Biophysical Research Communications, 200, 549–556.CrossRefPubMed
21.
Zurück zum Zitat Ingles, J., Doolan, A., Chiu, C., Seidman, J., Seidman, C., & Semsarian, C. (2005). Compound and double mutations in patients with hypertrophic cardiomyopathy: Implications for genetic testing and counselling. Journal of Medical Genetics, 42, e59.CrossRefPubMed Ingles, J., Doolan, A., Chiu, C., Seidman, J., Seidman, C., & Semsarian, C. (2005). Compound and double mutations in patients with hypertrophic cardiomyopathy: Implications for genetic testing and counselling. Journal of Medical Genetics, 42, e59.CrossRefPubMed
22.
Zurück zum Zitat Morita, H., Rehm, H. L., Menesses, A., McDonough, B., Roberts, A. E., Kucherlapati, R., et al. (2008). Shared genetic causes of cardiac hypertrophy in children and adults. The New England Journal of Medicine, 358, 1899–1908.CrossRefPubMed Morita, H., Rehm, H. L., Menesses, A., McDonough, B., Roberts, A. E., Kucherlapati, R., et al. (2008). Shared genetic causes of cardiac hypertrophy in children and adults. The New England Journal of Medicine, 358, 1899–1908.CrossRefPubMed
23.
Zurück zum Zitat Bhuiyan, Z. A., Jongbloed, J. D., van der Smagt, J., Lombardi, P. M., Wiesfeld, A. C., Nelen, M., et al. (2009). Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: Results from a multicenter study. Circulation: Cardiovascular Genetics, 2, 418–427.CrossRef Bhuiyan, Z. A., Jongbloed, J. D., van der Smagt, J., Lombardi, P. M., Wiesfeld, A. C., Nelen, M., et al. (2009). Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: Results from a multicenter study. Circulation: Cardiovascular Genetics, 2, 418–427.CrossRef
24.
Zurück zum Zitat Fressart, V., Duthoit, G., Donal, E., Probst, V., Deharo, J. C., Chevalier, P., et al. (2010). Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Spectrum of mutations and clinical impact in practice. Europace, 12, 861–868.CrossRefPubMed Fressart, V., Duthoit, G., Donal, E., Probst, V., Deharo, J. C., Chevalier, P., et al. (2010). Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Spectrum of mutations and clinical impact in practice. Europace, 12, 861–868.CrossRefPubMed
25.
Zurück zum Zitat Barahona-Dussault, C., Benito, B., Campuzano, O., Iglesias, A., Leung, T. L., Robb, L., et al. (2010). Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Clinical Genetics, 77, 37–48.CrossRefPubMed Barahona-Dussault, C., Benito, B., Campuzano, O., Iglesias, A., Leung, T. L., Robb, L., et al. (2010). Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Clinical Genetics, 77, 37–48.CrossRefPubMed
26.
Zurück zum Zitat Basso, C., Thiene, G., Corrado, D., Angelini, A., Nava, A., & Valente, M. (1996). Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation, 94, 983–991.PubMed Basso, C., Thiene, G., Corrado, D., Angelini, A., Nava, A., & Valente, M. (1996). Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation, 94, 983–991.PubMed
27.
Zurück zum Zitat Thiene, G., Nava, A., Corrado, D., Rossi, L., & Pennelli, N. (1988). Right ventricular cardiomyopathy and sudden death in young people. The New England Journal of Medicine, 318, 129–133.CrossRefPubMed Thiene, G., Nava, A., Corrado, D., Rossi, L., & Pennelli, N. (1988). Right ventricular cardiomyopathy and sudden death in young people. The New England Journal of Medicine, 318, 129–133.CrossRefPubMed
28.
Zurück zum Zitat Aronow, W. S., Mercando, A. D., & Epstein, S. (1995). Usefulness of an abnormal signal-averaged electrocardiogram for predicting cardiac death in elderly persons without heart disease. The American Journal of Cardiology, 75, 1273–1274.CrossRefPubMed Aronow, W. S., Mercando, A. D., & Epstein, S. (1995). Usefulness of an abnormal signal-averaged electrocardiogram for predicting cardiac death in elderly persons without heart disease. The American Journal of Cardiology, 75, 1273–1274.CrossRefPubMed
29.
Zurück zum Zitat Crotti, L., Lundquist, A. L., Insolia, R., Pedrazzini, M., Ferrandi, C., De Ferrari, G. M., et al. (2005). KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation, 112, 1251–1258.CrossRefPubMed Crotti, L., Lundquist, A. L., Insolia, R., Pedrazzini, M., Ferrandi, C., De Ferrari, G. M., et al. (2005). KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation, 112, 1251–1258.CrossRefPubMed
30.
Zurück zum Zitat Xu, T., Yang, Z., Vatta, M., Rampazzo, A., Beffagna, G., Pilichou, K., et al. (2010). Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. Journal of the American College of Cardiology, 55, 587–597.CrossRefPubMed Xu, T., Yang, Z., Vatta, M., Rampazzo, A., Beffagna, G., Pilichou, K., et al. (2010). Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. Journal of the American College of Cardiology, 55, 587–597.CrossRefPubMed
31.
Zurück zum Zitat Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., et al. (2010). Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the task force criteria. Circulation, 121, 1533–1541.CrossRefPubMed Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., et al. (2010). Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the task force criteria. Circulation, 121, 1533–1541.CrossRefPubMed
32.
Zurück zum Zitat Cox, M. G. P. J., van der Smagt, J. J., Noorman, M., Wiesfeld, A. C., Volders, P. G. A., van Langen, I. M., et al. (2010). Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: Impact of new task force criteria. Circulation: Arrhythmia Electrophysiology, 3, 126–133.CrossRef Cox, M. G. P. J., van der Smagt, J. J., Noorman, M., Wiesfeld, A. C., Volders, P. G. A., van Langen, I. M., et al. (2010). Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: Impact of new task force criteria. Circulation: Arrhythmia Electrophysiology, 3, 126–133.CrossRef
Metadaten
Titel
Shared Desmosome Gene Findings in Early and Late Onset Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
verfasst von
Boon Yew Tan
Rahul Jain
A. Dénise den Haan
Yan Chen
Darshan Dalal
Harikrishna Tandri
Nuria Amat-Alarcon
Amy Daly
Crystal Tichnell
Cynthia James
Hugh Calkins
Daniel P. Judge
Publikationsdatum
01.12.2010
Verlag
Springer US
Erschienen in
Journal of Cardiovascular Translational Research / Ausgabe 6/2010
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-010-9224-4

Weitere Artikel der Ausgabe 6/2010

Journal of Cardiovascular Translational Research 6/2010 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.